Objectives-To analyse major histocompatibility complex (MHC) haplotypes in Mexican mestizo patients with seronegative spondyloarthropathies (SSpA) and normal controls, to discover if there are other antigens, besides B27, in the HLA region that might show association with the disease. Methods-The study included 100 Mexican mestizo patients with SSpA and 200 of their first degree relatives. These groups were compared with 85 ethnically matched controls. The class I and class III MHC antigens were obtained by standard methods. The significance of differences between patients and controls was tested by x2 analysis; linkage disequilibrium among the different alleles in each haplotype was estimated by computing delta values. Results-We found a significantly increased frequency of the HLA-B27 antigen (pcorr. = 1 x 10-5, odds ratio (OR) = 334, 95% confidence interval (CI) = 9-3-142.0).
OR=3-7, 95% CI= 12-11-1) were found.
Significant delta values were obtained for the [B27;SC30] haplotype (p = 0.0005) but not for haplotypes marked by the FC31 complotype. HLA-B antigens on the homologous chromosome in B27 positive patients were mainly HLA-B51 (18%) and HLA-B60 (16%); however, the observed genotypes B27/B51 and B27/B60 were not significantly different than expected from the allele frequencies alone.
Conclusions-These data suggest that in Mexicans additional genes within the MHC region besides the HLA-B27 antigen, might be related to the genetic susceptibility for developing SSpA. Relevant antigens included the HLA-B49 and the FC31 complotype.
(Ann Rheum Dis 1994; 53: 755-758)
The histocompatibility antigen HLA-B27 is strongly associated with ankylosing spondylitis (AS) and related diseases.' Over 90% of the patients with AS, and 60-95% of the patients with Reiter's syndrome (RS) or associated spondyloarthropathies shared this antigen, compared with 6-8% of normal White controls." The pathogenic mechanisms responsible for this association and the role of HLA-B27 antigen in the development of these diseases are unknown.
Despite the very close association between B27 and AS, the presence of the antigen does not lead to the development of the disease. Only 1-3% of B27 positive individuals from the population develop AS. Conversely, a small proportion of AS patients do not carry B27. 5 6 This indicates that the antigen alone is neither necessary nor sufficient for the development of the disease.
Structural analysis of the HLA-B27 antigen has revealed the existence of multiple variants, or subtypes, in human populations. Several studies reported no differences in susceptibility to AS among the subtypes;7-9 nonetheless, Hill et all' proposed that the HIA-B*2703 subtype is not disease associated, thereby accounting for the low incidence of AS and reactive arthritis in West Africa where this subtype is prevalent. However, studies in patients from this ethnic group are needed to support this hypothesis.
It is generally accepted that the HLA-B27 antigen is implicated in disease but it has also been suggested that additional genetic and environmental factors seem to be necessary to confer the susceptibility to AS. positive White AS patients.'5 It appears that instead of B60, some other HLA linked genetic factors might play a role to increase further the susceptibility to the disease.
Subjects and methods

PATIENTS
We studied 100 consecutive Mexican patients with SSpA (88 men and 12 women) (mean age = 30 years), seen at the rheumatology outpatient clinic of the Instituto Nacional de la Nutricion Salvador Zubirain in Mexico City. To obtain major histocompatibility complex (MHC) haplotypes, 200 of their first degree relatives were also typed.
According to the European Spondyloarthropathy Study Group criteria,'6 our patients had inflammatory spinal pain or synovitis (asymmetric or predominantly in the lower limbs) together with at least one of the following clinical criteria: positive family history, urethritis, cervicitis, or acute diarrhoea within one month before arthritis, enthesopathy, sacroiliitis.
From the 100 SSpA patients, 50 fulfilled the New York criteria'7 for AS, whereas 40 had clinical diagnosis of RS.'8 Most of them had a non-gonococcal or postvenereal or postenteritic form(s) of the syndrome. The arthritis was not of a psoriatic type, and none of them had clinical manifestations related to inflammatory bowel diseases (Crohn's disease, or ulcerative colitis).
The clinical picture in 10 individuals was not clear enough to discriminate AS or RS, and they were considered as having undifferentiated spondyloarthropathy.
CONTROLS
Eighty five healthy Mexican individuals from 43 ethnically matched families (only parents were included for purposes of statistical analysis) were used as controls. Control individuals and their last two generations were born in Mexico City. Serological HLA typing. Venous blood samples were obtained from patients, relatives and controls. Lymphocytes were isolated using a density gradient centrifugation technique.'9 HLA-B typing was performed in T cells with a standard microlymphocytotoxicity test.20 Typing trays were purchased from C-Six Diagnostics (Mequon, WI, USA). Trays consisted of a total of 140 antisera to define 49 specificities from the A, B, and C, HLA loci.
Complement typing. Factor B (BF) typing was carried out by immunofixation after agarose gel electrophoresis of plasma samples2' using goat anti-human BF antibodies (Atlantic Antibodies, Stillwater, MN, USA). Neuraminidase-treated plasma samples were subjected to agarose gel electrophoresis and immunofixation with goat anti-human C4 antibodies (Atlantic Antibodies) for typing of C4A and C4B.22 C2 patterns were generated by isoelectric focusing of serum samples in polyacrylamide gel, and patterns were developed in a C2-sensitive agarose gel containing antibodysensitised sheep erythrocytes.23
The nomenclature for BF, C2 and C4 variants has been published previously.2'-23 Complotypes are given in arbitrary order as BF, C2, C4A and C4B alleles. For example, the most common complotype in healthy Mexicans, SC31, denotes BF*S, C2*C, C4A*3, C4B*1.
STATISTICAL ANALYSIS
The significance of the differences between groups was performed using Mantel-Haenszel x2 analysis which combined the 2 x 2 tables using the EPISTAT statistical program. The p values were corrected by the number of comparisons (16 for HLA-B and 8 for complotypes). Relative risks with 95% confidence interval (95% CI) were calculated as odds ratios (OR), also using the Mantel-Haenszel method.
In accordance with calculated the linkage value) as follows: We measured the difference between the frequency with which a pair of alleles has to occur in a single haplotype (expected frequency) and the real combination of both alleles in the studied population (observed frequency), bearing in mind that the individual frequencies are known. The delta value for a combination of phenotypes expresses the differences between the expected frequency and the observed frequency. The statistical significance of the delta value was tested by x2.
Results
HLA-B27 POSITIVE PATIENTS
Thirty five of 50 (70%) AS patients, 18 of 40 (45%) RS patients and two of 10 (20%) undifferentiated spondyloarthropathy patients were HLA-B27 positive.
Relevant HLA-B alleles in SSpA patients and in normal controls are shown in table 1; patients had a significantly increased frequency of HLA-B27 (pcorr.= 1 X 10-5, OR=33-4, 95% CI= 9-3-142). Other HLA-B alleles were equally distributed between patients and controls including the B27 CREG (B7, B22, B42) antigens.
HLA-B antigens on the homologous chromosomes in B27 positive patients were mainly HLA-B51 (18%) and HLA-B60 (16%); however, the observed genotypes B27/B51 and B27/B60 (observed frequency = 0 100 and 0-090, respectively) were not significantly different than expected from the allele frequencies alone (expected frequency = 0-059 and 0 039, respectively). 
